These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 21421331

  • 1. Stroke in a child safely treated with intravenous tissue plasminogen activator and edaravone, a free radical scavenger.
    Baba H, Sugimori H, Nanishi E, Nagata H, Lee S, Kuwashiro T, Hashizume M.
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):903.e5-8. PubMed ID: 21421331
    [Abstract] [Full Text] [Related]

  • 2. Outcome of Acute Ischemic Stroke after the Treatment with Edaravone and 0.6 Mg/Kg Alteplase in Japanese Patients with Diabetes.
    Tanahashi N, Yamaguchi T, Awano H, Matsuda H.
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1302-1310. PubMed ID: 29373227
    [Abstract] [Full Text] [Related]

  • 3. Three cases of middle cerebral artery occlusion emergently revascularized with a balloon-expandable coronary bare stent after intravenous tissue plasminogen activator.
    Fukuoka T, Dembo T, Nagoya H, Deguchi I, Maruyama H, Kanazawa R, Kohyama S, Yamane F, Ishihara S, Tanahashi N.
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):883-9. PubMed ID: 21767964
    [Abstract] [Full Text] [Related]

  • 4. Effects of edaravone, a free radical scavenger, on circulating levels of MMP-9 and hemorrhagic transformation in patients with intravenous thrombolysis using low-dose alteplase.
    Tsuruoka A, Atsumi C, Mizukami H, Imai T, Hagiwara Y, Hasegawa Y.
    J Stroke Cerebrovasc Dis; 2014 Nov; 23(10):2894-2899. PubMed ID: 25282183
    [Abstract] [Full Text] [Related]

  • 5. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
    Hassan AE, Zacharatos H, Hassanzadeh B, El-Gengaihy A, AlKawi A, Shhadeh A, Kirmani JF.
    J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
    [Abstract] [Full Text] [Related]

  • 6. [Intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke in a local university hospital].
    Takahashi K, Iijima K, Oguro H, Bokura H, Nagai A, Yamaguchi S, Kobayashi S.
    No To Shinkei; 2005 Aug; 57(8):683-8. PubMed ID: 16146212
    [Abstract] [Full Text] [Related]

  • 7. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report.
    Matsuzaki T, Yoshino A, Sakatani K, Katayama Y.
    J Stroke Cerebrovasc Dis; 2011 Aug; 20(3):269-72. PubMed ID: 20630773
    [Abstract] [Full Text] [Related]

  • 8. Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients--a preliminary study.
    Kimura K, Aoki J, Sakamoto Y, Kobayashi K, Sakai K, Inoue T, Iguchi Y, Shibazaki K.
    J Neurol Sci; 2012 Feb 15; 313(1-2):132-6. PubMed ID: 21967833
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous administration of recombinant tissue plasminogen activator and edaravone in acute cerebral ischemic stroke patients.
    Takenaka K, Kato M, Yamauti K, Hayashi K.
    J Stroke Cerebrovasc Dis; 2014 Feb 15; 23(10):2748-2752. PubMed ID: 25307430
    [Abstract] [Full Text] [Related]

  • 10. Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5).
    Yamaguchi T, Awano H, Matsuda H, Tanahashi N, PROTECT4.5 Investigators.
    J Stroke Cerebrovasc Dis; 2017 Apr 15; 26(4):756-765. PubMed ID: 27887792
    [Abstract] [Full Text] [Related]

  • 11. Edaravone: a new therapeutic approach for the treatment of acute stroke.
    Kikuchi K, Kawahara K, Miyagi N, Uchikado H, Kuramoto T, Morimoto Y, Tancharoen S, Miura N, Takenouchi K, Oyama Y, Shrestha B, Matsuda F, Yoshida Y, Arimura S, Mera K, Tada K, Yoshinaga N, Maenosono R, Ohno Y, Hashiguchi T, Maruyama I, Shigemori M.
    Med Hypotheses; 2010 Dec 15; 75(6):583-5. PubMed ID: 20728280
    [Abstract] [Full Text] [Related]

  • 12. Characteristics and outcome of ischemic stroke patients who are free of symptoms at 24 hours following thrombolysis.
    Strbian D, Sairanen T, Rantanen K, Piironen K, Atula S, Tatlisumak T, Soinne L, Helsinki Stroke Thrombolysis Registry Group.
    Cerebrovasc Dis; 2011 Dec 15; 31(1):37-42. PubMed ID: 20980752
    [Abstract] [Full Text] [Related]

  • 13. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL, Zaidat OO.
    J Stroke Cerebrovasc Dis; 2008 Dec 15; 17(3):121-8. PubMed ID: 18436152
    [Abstract] [Full Text] [Related]

  • 14. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y, Drescher MJ, Merzeliak O, Tsabari R, Bruk B, Feibel M, Hoffman C, Bakon M, Rotstein Z, Chapman J, Tanne D.
    Isr Med Assoc J; 2004 Feb 15; 6(2):70-4. PubMed ID: 14986460
    [Abstract] [Full Text] [Related]

  • 15. Effects of edaravone on early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator.
    Wada T, Yasunaga H, Inokuchi R, Horiguchi H, Fushimi K, Matsubara T, Nakajima S, Yahagi N.
    J Neurol Sci; 2014 Oct 15; 345(1-2):106-11. PubMed ID: 25085762
    [Abstract] [Full Text] [Related]

  • 16. Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study.
    Messé SR, Kasner SE, Cucchiara BL, Demchuk A, Tanne D, Ouyang B, Levine SR, NINDS t-PA Stroke Study Group.
    J Stroke Cerebrovasc Dis; 2011 Oct 15; 20(3):236-40. PubMed ID: 20656508
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke.
    Kimura K, Iguchi Y, Yamashita S, Shibazaki K, Kobayashi K, Inoue T.
    J Neurol Sci; 2008 Apr 15; 267(1-2):57-61. PubMed ID: 17964602
    [Abstract] [Full Text] [Related]

  • 19. Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry.
    Kamouchi M, Sakai H, Kiyohara Y, Minematsu K, Hayashi K, Kitazono T.
    J Stroke Cerebrovasc Dis; 2013 Nov 15; 22(8):e470-6. PubMed ID: 23800495
    [Abstract] [Full Text] [Related]

  • 20. Barriers to the use of intravenous tissue plasminogen activator for in-hospital strokes.
    Bunch ME, Nunziato EC, Labovitz DL.
    J Stroke Cerebrovasc Dis; 2012 Nov 15; 21(8):808-11. PubMed ID: 21640608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.